drugset / Trial / NCT04019743

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

NCT04019743

Phase 1 Completed 24 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, fasted, single dose, crossover study to investigate the pharmacokinetic profiles and safety of CKD-333 in healthy volunteers.

Timeline

Start
2019-07-28
Primary completion
2019-08-30
Completion
2019-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-330 Unknown Oral
Subject CKD-333 Unknown Oral
Subject D086 Unknown Oral